Clinician Resources | Overview
Our role in the medical community is one we value very deeply. As a referral hospital we are a collaborative partner, establishing and maintaining clear lines of communications with referring physicians throughout treatment. We take leadership roles in organizations that advance the way pediatric cancer and blood disorders are treated around the globe. And our fellowship program has trained more leaders in the pediatric hematology and oncology field than any other. Continue reading to learn more, or contact us to refer a patient or request a second opinion.
Outcomes
- More than 100 stem cell transplants performed a year
- 165 specialists
- More than 150 diseases treated
- Access to more than 200 therapeutic clinical trials
- About 700 new patients and 3,000 unique patients seen a year
- More than 14,000 exams and 9,000 infusions a year performed in the Jimmy Fund Clinic
For referring physicians
As a physician who wants the best for your patients, you can feel confident entrusting their care to Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.
Our program brings together renowned hematologists and oncologists from Boston Children’s Hospital and Dana-Farber Cancer Institute. Our faculty is comprised of internationally recognized leaders, including David Williams, MD; Lisa Diller, MD; Lindsay Frazier, MD; Holcombe Grier, MD; Matthew Heeney, MD; Leslie Lehmann, MD; Karen Marcus, MD; Stephen Sallan, MD; Suzanne Shusterman, MD; and Lewis Silverman, MD; among others.
Our patients benefit from a multidisciplinary team of physicians who specialize in treating children and adolescents with cancer and blood disorders. We surround our specialists with a vast community of pediatric subspecialists to provide your patient an unrivaled breadth of expertise across disciplines, including nursing, pathology, radiology, surgery, diagnostic imaging, neurology, and orthopedics. Psychological and emotional support is provided by psychologists, child life specialists, and clinical social workers. The spectrum and depth of care we provide, from diagnosis to survivorship, is unparalleled.
Research and clinical trials
With more than 200 active clinical trials at any given time, we are committed to innovating new methods of how pediatric cancer and blood disorders are diagnosed and treated. Among our many trials are studies to develop innovative therapies such as immunotherapy and gene therapy. We are also a leader in the integration of personalized medicine into treatment methodologies.
Educational opportunities
Our experts are frequent speakers at conferences and seminars, including the annual meetings for the American Society for Hematology (ASH), International Society of Pediatric Oncology (SIOP), American Society of Pediatric Hematology/Oncology (ASPHO), and the Society for Neuro-Oncology.
Fellowship program
The Pediatric Hematology/Oncology Fellowship Program at Dana-Farber/Boston Children's is one of the most recognized in the nation. This program has trained more leaders in the hematology and oncology field than any other. The objective of the training program is to provide the highest quality clinical and research training in hematology/oncology, so that our fellows become excellent clinicians and independent investigators making substantive contributions to biomedical research.